DrugDashboards

Market view

risankizumab-rzaa · Injection, Solution

2 marketed package NDCs · 1 active manufacturer

Most dispensed: RISANKIZUMAB 150 mg/mL · Injection · #1 syringe/carton / 1 ml in 1 syringe · Kit · #1 kit/carton * 2.4 ml in 1 cartridge * 2.4 ml in 1 cartridge

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for risankizumab-rzaa, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • SkyriziAug 19, 2026
    Price up
    NADAC $22731.99409 → $22761.4629 per unit (+0.13%)
  • SkyriziAug 19, 2026
    Price up
    NADAC $9537.27153 → $9565.60052 per unit (+0.3%)
  • SkyriziAug 19, 2026
    Price up
    NADAC $22757.35 → $22887.43857 per unit (+0.57%)
  • SkyriziJul 22, 2026
    Price down
    NADAC $9679.49213 → $9537.27153 per unit (-1.47%)
  • SkyriziJul 22, 2026
    Price down
    NADAC $22942.37158 → $22757.35 per unit (-0.81%)
  • SkyriziJul 22, 2026
    Price up
    NADAC $22710.11211 → $22731.99409 per unit (+0.1%)

Same drug class

Other molecules FDA puts in Interleukin-23 Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Risankizumab-rzaa in shortage right now?
No. FDA does not currently list Risankizumab-rzaa in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Risankizumab-rzaa?
1 company has marketed Risankizumab-rzaa in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
What does Risankizumab-rzaa cost?
The typical pharmacy pays about $22,761.46 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.